Aktiespot

Divi's Laboratories Limited (DIVI S LABORATORIES LTD) Aktie

DIVISLAB.NS

₹6,576.50+43.50 (+0.67%)
Chart wird geladen...
DIVI S LABORATORIES LTD Logo

DIVI S LABORATORIES LTD

Eröffnung6,520.00
Hoch6,604.50
Tief6,460.00
Volumen563.16k
P/E68.02
Marktkapitalisierung1.75T
52-Wochen-Hoch7,071.50
52-Wochen-Tief5,636.50
Durchschn. Volumen317.12k
DividendeN/A
Beta0.22
EPS96.69

Über Divi's Laboratories Limited (DIVI S LABORATORIES LTD) Aktie

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as lutein and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

Unternehmensinformationen

Börse: NSE (NSI)
Sektor: Sundhed
Branche: Lægemiddelproducenter – Special og generisk
Adresse:
Divi Towers
500032 Hyderabad, India
Telefon: + 91 40 6696 6300

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Anbefaling:2.57 - hold
Niedrigstes Kursziel
5,160.00
21.5%
Durchschnittliches Kursziel
7,055.50
7.3%
Median Kursziel
6,981.00
6.2%
Höchstes Kursziel
9,140.00
39.0%

Andere sehen auch: